AptaPharma Inc.
AptaPharma Inc. appears in FDA public data with 1 recall, 0 510(k) clearances, 5 FDA inspections, and 0 compliance actions on record. Its most recent recall (D-0787-2022, Class III) was initiated on March 29, 2022.
Summary
- Total Recalls
- 1
- 510(k) Clearances
- 0
- Inspections
- 5
- Compliance Actions
- 0
Recent Recalls
| Number | Class | Product | Date |
|---|---|---|---|
| D-0787-2022 | Class III | Wal-Tussin DM (dextromethorphan HBr/Guaifenesin), 12 FL OZ (354 mL) bottles, Distributed By: Walgree | March 29, 2022 |